These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9533973)

  • 41. TCAs or SSRIs as initial therapy for depression?
    Tyra JM; Greenawald MH
    J Fam Pract; 1999 Nov; 48(11):845-6. PubMed ID: 10907616
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
    J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
    Feighner JP; Cohn JB
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. If everyone were on Prozac...
    Gupta S
    Time; 2003 Jan; 161(3):81. PubMed ID: 12545568
    [No Abstract]   [Full Text] [Related]  

  • 46. Antidepressants in the treatment of migraine headache.
    Punay NC; Couch JR
    Curr Pain Headache Rep; 2003 Feb; 7(1):51-4. PubMed ID: 12525271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SSRI-TCA combination in the treatment of resistant depression.
    Terao T; Ikemura N
    J Clin Psychiatry; 2000 Jul; 61(7):529. PubMed ID: 10937615
    [No Abstract]   [Full Text] [Related]  

  • 48. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
    Feiger AD; Flament MF; Boyer P; Gillespie JA
    Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prozac vs. placebos.
    Noonan D; Cowley G
    Newsweek; 2002 Jul; 140(3):48-9. PubMed ID: 12150021
    [No Abstract]   [Full Text] [Related]  

  • 51. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.
    Strober M; DeAntonio M; Schmidt-Lackner S; Pataki C; Freeman R; Rigali J; Rao U
    J Clin Psychiatry; 1999 Mar; 60(3):164-9. PubMed ID: 10192591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poststroke depression.
    Franco K; Malhotra S
    Am J Psychiatry; 2001 Apr; 158(4):658-60. PubMed ID: 11282720
    [No Abstract]   [Full Text] [Related]  

  • 55. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
    Manoharan A; Shewade DG; Rajkumar RP; Adithan S
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment.
    Fraguas R; Marci C; Fava M; Iosifescu DV; Bankier B; Loh R; Dougherty DD
    Psychiatry Res; 2007 May; 151(1-2):169-72. PubMed ID: 17360044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressants and heart-rate variability in older adults: a population-based study.
    Noordam R; van den Berg ME; Niemeijer MN; Aarts N; Hofman A; Tiemeier H; Kors JA; Stricker BH; Eijgelsheim M; Visser LE; Rijnbeek PR
    Psychol Med; 2016 Apr; 46(6):1239-47. PubMed ID: 26679009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.